| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 46.80B | 39.20B | 36.84B | 31.09B | 33.21B | 32.08B |
| Gross Profit | 36.31B | 30.85B | 29.04B | 23.47B | 27.51B | 26.47B |
| EBITDA | 22.44B | 19.83B | 17.50B | 14.01B | 19.16B | 17.03B |
| Net Income | 13.09B | 10.50B | 9.79B | 7.82B | 11.44B | 10.28B |
Balance Sheet | ||||||
| Total Assets | 1.28T | 1.12T | 1.17T | 976.03B | 879.39B | 961.79B |
| Cash, Cash Equivalents and Short-Term Investments | 100.60B | 105.70B | 104.47B | 79.33B | 57.30B | 620.96B |
| Total Debt | 268.40B | 313.93B | 281.81B | 489.66B | 175.38B | 217.36B |
| Total Liabilities | 1.21T | 1.05T | 1.10T | 899.67B | 800.67B | 882.58B |
| Stockholders Equity | 77.63B | 76.60B | 76.33B | 76.35B | 78.72B | 79.21B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -113.86B | 143.74B | 7.45B | 21.71B | 3.65B |
| Operating Cash Flow | 0.00 | -113.43B | 144.40B | 7.95B | 22.01B | 4.08B |
| Investing Cash Flow | 0.00 | -8.68B | -8.82B | -5.95B | -33.00M | -1.78B |
| Financing Cash Flow | 0.00 | 53.20B | 8.62B | 41.92B | -50.37B | 117.99B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥85.15B | 6.63 | ― | 5.75% | 10.85% | 30.77% | |
80 Outperform | ¥183.43B | 6.74 | ― | 4.01% | -2.39% | -4.54% | |
76 Outperform | ¥1.98T | 10.19 | 9.37% | 4.13% | -0.87% | 6.88% | |
73 Outperform | ¥3.49T | 10.42 | 10.23% | 3.93% | -2.45% | 35.60% | |
69 Neutral | ¥248.06B | 12.14 | 14.00% | 5.13% | 3.27% | -1.81% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
43 Neutral | ¥175.73B | 13.27 | 7.26% | 4.16% | 14.69% | -114.36% |